Ritter Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch RTTR and buy or sell other stocks, ETFs, and their options commission-free!

About RTTR

Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat digestive disorders and gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. 

CEO
Andrew J. Ritter, MBA
CEOAndrew J. Ritter, MBA
Employees
—
Employees—
Headquarters
Los Angeles, California
HeadquartersLos Angeles, California
Founded
2004
Founded2004
Employees
—
Employees—

RTTR Key Statistics

Market cap
6.14M
Market cap6.14M
Price-Earnings ratio
-0.07
Price-Earnings ratio-0.07
Dividend yield
—
Dividend yield—
Average volume
17.65K
Average volume17.65K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$29.44
52 Week high$29.44
52 Week low
$2.85
52 Week low$2.85

People also own

Based on the portfolios of people who own RTTR. This list is generated using Robinhood data, and it’s not a recommendation.
Titan Pharmaceuticals
iBio
Biocept
Vislink Technologies
Seanergy
Zomedica Pharmaceuticals
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.